Solana (SOL): I Want to Trade This!
1 extracted signal · 0 resolved · 1 still active
FJ TradingIndependent analyst profile- Source published
- 30 Oct 2026, 16:16 UTC
- Recorded by Tahlil Plus
- 30 Oct 2026, 20:15 UTC
AI-generated source summary
The analysis focuses on Solana (SOLUSDT) on a daily chart timeframe. The current price is observed at $96.75, with a predicted bullish trend. The target price is set at $137.94, indicating a potential upside. The fail bound, below which the bullish analysis would be invalidated, is set at $83.87. The speaker has been anticipating this setup for weeks, waiting for the price to break above a specific bullish order block between $95.25 and $97.77. A successful retest of this zone as support is considered a key entry trigger. The speaker also mentions that if the price were to close below $83.87, the setup would be invalidated, and they would consider a bearish scenario. The broader market context is not detailed, but the immediate focus is on capturing this potential long position based on the identified bullish order block and support level. The analysis highlights the importance of the daily candle close and subsequent confirmation before entering a trade.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
FJ Trading
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.